Characterizing the proteome of the human dorsolateral prefrontal cortex by shotgun mass spectrometry

Proteomics

Volumn 11, Issue 11, 2011, Pages 2347-2353

  Martins de Souza, Daniel ^a,b   Guest, Paul C ^a   Steeb, Hannah ^a   Pietsch, Sandra ^a   Rahmoune, Hassan ^a   Harris, Laura W ^a   Bahn, Sabine ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Biomedicine; Brain; Gel electrophoresis; MS; Synapse

Indexed keywords

BRAIN PROTEIN; PROTEOME;

ARTICLE; BRAIN REGION; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION;

DATABASES, PROTEIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MASS SPECTROMETRY; NERVE TISSUE PROTEINS; PEPTIDE MAPPING; PREFRONTAL CORTEX; PROTEOME; PROTEOMICS;

EID: 79956270352     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000718     Document Type: Article

References (26)

1. Miller, E. K., Cohen, J. D., An integrative theory of prefrontal cortex function. Annu. Rev. Neurosci. 2001, 24, 167-202.
2. Bonelli, R. M., Cummings, J. L., Frontal-subcortical circuitry and behavior. Dialogues Clin. Neurosci. 2007, 9, 141-151.
3. Pan, S., Shi, M., Jin, J., Albin, R. L. et al., Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer. Mol. Cell. Proteomics 2007, 6, 1818-1823.
4. Martins-de-Souza, D., Maccarrone, G., Reckow, S., Falkai, P. et al., Shotgun mass spectrometry analysis of the human thalamus proteome. J. Sep. Sci. 2009, 32, 1231-1236.
5. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Rewerts, C. et al., Proteome analysis of human dorsolateral prefrontal cortex using shotgun mass spectrometry. J. Sep. Sci. 2008, 31, 3122-3126.
6. Martins-de-Souza, D., Menezes de Oliveira, B., dos Santos Farias, A., Horiuchi, R. S. et al., The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis. Brief. Funct. Genomic. Proteomic. 2007, 6, 70-75.
7. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
8. Levin, Y., Wang, L., Schwarz, E., Koethe, D. et al., Global proteomic profiling reveals altered proteomic signature in schizophrenia serum. Mol. Psychiatry 2010, 15, 1088-1100.
9. Li, G. Z., Vissers, J. P., Silva, J. C., Golick, D. et al., Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics 2009, 9, 1696-1719.
10. Vizcaino, J. A., Cote, R., Reisinger, F., Foster, J. M. et al., A guide to the Proteomics Identifications Database proteomics data repository. Proteomics 2009, 9, 4276-4283.
11. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Rewerts, C. et al., Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J. Neural Transm. 2009, 116, 275-289.
12. Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J. et al., Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 2004 9, 684-697.
13. Pennington, K., Beasley, C. L., Dicker, P., Fagan, A. et al., Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol. Psychiatry 2008, 13, 1102-1117.
14. Uhlén, M., Björling, E., Agaton, C., Szigyarto, C. A. et al., A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol. Cell. Proteomics 2005, 4, 1920-1932.
15. Lockstone, H. E., Harris, L. W., Swatton, J. E., Wayland, M. T. et al., Gene expression profiling in the adult Down syndrome brain. Genomics 2007, 90, 647-660.
16. Hancock, W. S., Wu, S. L., Shieh, P., The challenges of developing a sound proteomics strategy. Proteomics 2002, 2, 352-359.
17. Kubota, K., Kosaka, T., Ichikawa, K., Combination of two-dimensional electrophoresis and shotgun peptide sequencing in comparative proteomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005, 815, 3-9.
18. Martins de Souza, D., Oliveira, B. M., Castro-Dias, E., Winck, F. V. et al., The untiring search for the most complete proteome representation: reviewing the methods. Brief. Funct. Genomic. Proteomic. 2008, 7, 312-321.
19. Martins-de-Souza, D., Maccarrone, G., Wobrock, T., Zerr, I. et al., Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia. J. Psychiatr. Res. 2010, 44, 1176-1189.
20. Thiede, B., Otto, A., Zimny-Arndt, U., Müller, E. C., Jungblut, P., Identification of human myocardial proteins separated by two-dimensional electrophoresis with matrix-assisted laser desorption/ionization mass spectrometry. Electrophoresis 1996, 17, 588-599.
21. Leitner, A., Lindner, W., Applications of chemical tagging approaches in combination with 2DE and mass spectrometry. Methods Mol. Biol. 2009, 519, 83-101.
22. Gotz, S., Garcia-Gomez, J. M., Terol, J., Williams, T. D. et al., High-throughput functional annotation and data mining with the Blast2GO suite. Nucleic Acids Res. 2008, 36, 3420-3435.
23. Ordys, B. B., Launay, S., Deighton, R. F., McCulloch, J. et al., The role of mitochondria in glioma pathophysiology. Mol. Neurobiol. 2010, 42, 64-75.
24. Scaglia, F., The role of mitochondrial dysfunction in psychiatric disease. Dev. Disabil. Res. Rev. 2010, 16, 136-143.
25. Müller, W. E., Eckert, A., Kurz, C., Eckert, G. P. et al., Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease - therapeutic aspects. Mol. Neurobiol. 2010, 41, 159-171.
26. Yoshida, C., Ishikawa, T., Michiue, T., Quan, L. et al., Postmortem biochemistry and immunohistochemistry of chromogranin A as a stress marker with special regard to fatal hypothermia and hyperthermia. Int. J. Legal Med. 2011, 125, 11-20.